AdvisorShares Pure US Cannabis ETF (MSOS)

NYSEArca

3.91
-0.17 (-4.17%)
Updated Oct 24, 4:15 AM ET
AI Rating
Sell
Overall Score
35
Trend
37
Momentum
20
Risk
52

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Oct 9, 2025 260 sessions Oct 21, 2026

AI Analysis

AdvisorShares Pure US Cannabis ETF is trading at $3.94, down 3.43% on the session. The 50 day average sits at $4.70 and the 200 day at $4.47, which puts the stock in a uptrend. RSI is at 40.5, which reads as weak, and MACD is bearish crossover. Volume is average.

The nearest support is around $3.88 with resistance near $4.74, so that band frames the current range. Average daily movement is roughly $0.22, or about 5.7% of the share price, which is what any stop placement has to allow for. The overall health score of 33 out of 100 combines a trend score of 37, momentum of 20 and a risk score of 46.

Technical indicators

RSI (14)
40.5
weak
MACD
-0.234
bearish crossover
SMA 20
4.42
SMA 50
4.70
SMA 200
4.47
uptrend
ATR (14)
0.22
avg daily range
Support
3.88
Resistance
4.74
Volume vs 20d
1.09x
average
Volatility
58.3%
annualised
1 month
-22.51%
3 months
-3.28%

About AdvisorShares Pure US Cannabis ETF

The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from the marijuana and hemp business in the United States and in derivatives that have economic characteristics similar to such securities. It will concentrate at least 25% of its investments in the pharmaceuticals, biotechnology & life sciences industry group within the health care sector. The fund is non-diversified.

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.